Bagnaria Arsa, Italy

Mojca Tajnik Sbaizero

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bluesky Immunotherapies Gmbh. Active years: 2022.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mojca Tajnik Sbaizero: Innovator in Virus Purification Technology

Introduction

Mojca Tajnik Sbaizero is a notable inventor based in Bagnaria Arsa, Italy. She has made significant contributions to the field of virus purification, showcasing her expertise through her innovative patent. Her work is essential in advancing methods for purifying virus particles, which is crucial for various applications in biotechnology and medicine.

Latest Patents

Mojca holds a patent for a process titled "SO3 chromatography for use in a method for virus purification." This invention outlines a method for purifying virus particles from cell culture. The process involves several steps, including centrifugation to obtain a supernatant fraction of virus particles, incubation with a nuclease, dilution with a low conductivity buffer, and the application of SO3 chromatography. The method concludes with a washing step and the elution of virus particles, demonstrating a comprehensive approach to virus purification.

Career Highlights

Mojca is currently associated with Bluesky Immunotherapies GmbH, where she applies her innovative techniques in a professional setting. Her work at the company emphasizes the importance of her contributions to the field of immunotherapy and virus research.

Collaborations

Mojca collaborates with esteemed colleagues, including Markus Wolschek and Manfred Reiter. These partnerships enhance her research and development efforts, fostering an environment of innovation and shared knowledge.

Conclusion

Mojca Tajnik Sbaizero is a pioneering inventor whose work in virus purification technology is making a significant impact in the field. Her patent and collaborations reflect her commitment to advancing scientific knowledge and improving therapeutic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…